chenodeoxycholic acid has been researched along with Barrett Esophagus in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fang, DC; Sun, YG; Wang, HB; Wang, RQ; Wang, WQ; Wang, XW; Yang, SM; Zhou, G | 1 |
Blain, SW; Gress, F; Nguyen, KD; Treem, WR | 1 |
Attwood, SE; Hardy, R; Harper, E; Harrison, R; Jankowski, JA; Luong, QT; Morris, CD; Perry, I; Tselepis, C; Wakelin, D | 1 |
Hainaut, P; Hautefeuille, A; Mion, F; Pétré, A; Roman, S; Scoazec, JY; Thépot, A | 1 |
Ajani, J; Buttar, NS; Chen, CT; Chou, CK; Guha, S; Hsu, JM; Huang, P; Hung, MC; Izzo, JG; Kuo, HP; Lee, DF; Sun, HL; Wang, KK; Wei, Y; Wu, TT; Yen, CJ | 1 |
5 other study(ies) available for chenodeoxycholic acid and Barrett Esophagus
Article | Year |
---|---|
Inhibition of nucleostemin upregulates CDX2 expression in HT29 cells in response to bile acid exposure: implications in the pathogenesis of Barrett's esophagus.
Topics: Barrett Esophagus; Biopsy; Blotting, Western; Carrier Proteins; Cathartics; CDX2 Transcription Factor; Chenodeoxycholic Acid; Esophagus; Gene Expression Regulation, Neoplastic; GTP-Binding Proteins; Homeodomain Proteins; HT29 Cells; Humans; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm | 2009 |
Inflammatory mediators of esophagitis alter p27 Kip1 expression in esophageal epithelial cells.
Topics: Barrett Esophagus; Biological Transport; Biomarkers; Cell Line; Cell Nucleus; Cell Proliferation; Chenodeoxycholic Acid; Cyclin-Dependent Kinase Inhibitor p27; Cytoplasm; Eosinophil Granule Proteins; Eosinophilic Esophagitis; Eosinophils; Epithelial Cells; Esophageal Neoplasms; Flow Cytometry; Gastroesophageal Reflux; Humans; Hydrochloric Acid; Inflammation Mediators | 2010 |
Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro.
Topics: Adenocarcinoma; Barrett Esophagus; Bile Acids and Salts; Blotting, Western; Cell Division; Chenodeoxycholic Acid; Deoxycholic Acid; Esophageal Neoplasms; Fluorescent Antibody Technique; Gastroesophageal Reflux; Gene Expression Regulation; Genes, myc; Humans; Immunohistochemistry; Polymerase Chain Reaction; Tumor Cells, Cultured; Up-Regulation | 2003 |
Downregulation of p63 upon exposure to bile salts and acid in normal and cancer esophageal cells in culture.
Topics: Acetylcysteine; Apoptosis; Barrett Esophagus; Carcinoma, Squamous Cell; Cell Line, Tumor; Cells, Cultured; Chenodeoxycholic Acid; Cyclooxygenase 2; Deoxycholic Acid; DNA-Binding Proteins; Down-Regulation; Doxorubicin; Esophageal Neoplasms; Esophagus; Fluorescent Antibody Technique; Humans; Hydrogen-Ion Concentration; Leupeptins; Proteasome Inhibitors; Taurochenodeoxycholic Acid; Trans-Activators; Transcription Factors; Tumor Suppressor Proteins | 2007 |
Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
Topics: Adenocarcinoma; Barrett Esophagus; Bile Acids and Salts; Cell Division; Chenodeoxycholic Acid; Esophageal Neoplasms; Gastroesophageal Reflux; Gene Expression Regulation, Neoplastic; Humans; Inflammation; NF-kappa B; Nitriles; Protein Kinases; RNA, Small Interfering; Sirolimus; Sulfones; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins; Ursodeoxycholic Acid | 2008 |